The final response depends on several factors including the final concentration of ATP, degradation rate to adenosine, and the specific subtypes of purinergic receptors expressed in each particular type of tumor, and by its associated inflammatory cells (Di Virgilio, 2012). The gene discussed is P2RX1; the disease is neoplasm.